Bamlanivimab Efficacy in Older and High-BMI Outpatients With COVID-19 Selected for Treatment in a Lottery-Based Allocation Process

BACKGROUND: Given the challenges associated with timely delivery of monoclonal antibody (mAb) therapy to outpatients with coronavirus disease 2019 (COVID-19) who are most likely to benefit, it is critical to understand the effectiveness of such therapy outside the context of clinical trials. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubin, Emily B, Boiarsky, Jonathan A, Canha, Lauren A, Giobbie-Hurder, Anita, Liu, Mofei, Townsend, Matthew J, Dougan, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651159/
https://www.ncbi.nlm.nih.gov/pubmed/34888396
http://dx.doi.org/10.1093/ofid/ofab546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651159/
https://www.ncbi.nlm.nih.gov/pubmed/34888396
http://dx.doi.org/10.1093/ofid/ofab546

Ejemplares similares